StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia.
Hypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy.
We can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Saad Building, Block Y, Cromore Road., Coleraine,derry Bt52 1sa,united Kingdom
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.stimoxygen.com
- HQ
- Coleraine, Derry
Stimoxygen Questions
Stimoxygen's website is http://www.stimoxygen.com
Stimoxygen's LinkedIn profile is https://uk.linkedin.com/company/stimoxygen
Stimoxygen has
4 employees.
View email and phone details for 4
employees at Stimoxygen.
Stimoxygen's industry is
Research Services
Stimoxygen's top competitors are
Ailsebio,
Proaxsis,
Amply Discovery,
Exrt Intelligent Healthcare,
Respiratory Analytics,
Raidmed,
Fusion Antibodies,
Causeway Sensors Limited,
Celerion,
Dia Beta Labs Ltd.
Stimoxygen's categories are Research Services
Stimoxygen's founding year is 2021
